European patent opposition outcomes in biotechnology

IF 2.2 Q2 INFORMATION SCIENCE & LIBRARY SCIENCE

World Patent Information Pub Date : 2023-06-01 DOI:10.1016/j.wpi.2023.102185

Lorena M. D'Agostino, Lorenzo Tiraboschi, Salvatore Torrisi

引用次数: 0

Abstract

Oppositions to patent grants are a means to attack competitors and protect a firm's own patent portfolio. Extant literature has analyzed the determinants of oppositions, while the drivers of opposition outcomes are less known. We study 290 EPO biotech patent oppositions filed in 2012–2019. There are three possible outcomes of opposition proceedings: patent revocation, patent amendment, and opposition rejection. We find that opponents who know the patent's technology are more likely to obtain a patent revocation, while opponents who compete in the product market with the patent owner are more likely to receive a rejection.

查看原文本刊更多论文

生物技术领域的欧洲专利反对结果

反对专利授权是攻击竞争对手和保护公司自己专利组合的一种手段。现存的文献分析了反对的决定因素，而反对结果的驱动因素却鲜为人知。我们研究了2012-2019年提交的290个欧洲专利局生物技术专利异议。异议程序有三种可能的结果:专利撤销、专利修改和异议驳回。我们发现，知道专利技术的对手更有可能获得专利撤销，而与专利权人在产品市场上竞争的对手更有可能获得驳回。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World Patent Information INFORMATION SCIENCE & LIBRARY SCIENCE-

CiteScore

3.50

自引率

18.50%

发文量

期刊介绍： The aim of World Patent Information is to provide a worldwide forum for the exchange of information between people working professionally in the field of Industrial Property information and documentation and to promote the widest possible use of the associated literature. Regular features include: papers concerned with all aspects of Industrial Property information and documentation; new regulations pertinent to Industrial Property information and documentation; short reports on relevant meetings and conferences; bibliographies, together with book and literature reviews.